Insurance Sector Accounting

First published 22 Aug 2026 · Last verified 29 Aug 2026

Contractual reserves swell, reported "profit" stays flat, and the share price does something else entirely — this is the moment most Nepali retail investors give up on reading an insurance company's financial statements and fall back on the dividend history instead. That surrender is a mistake, and an expensive one, because insurance is one of the few NEPSE sectors where the accounting itself — not the underlying business — determines what the reported number means in a given year. A life or non-life insurer's income statement is not a scorecard of commercial success in the way a manufacturer's or a bank's is; it is the output of a set of actuarial assumptions, a regulatory reserving formula, and, since mid-2023, a brand-new accounting standard that Nepal's own insurers are still learning to apply consistently. This chapter builds the toolkit to read through that machinery.

Lesson 33.1 — Why an Insurer's Balance Sheet Looks Nothing Like a Normal Company's

Start with the basic asymmetry that makes insurance accounting a distinct discipline. A trading or manufacturing company sells a good today and, mostly, knows its cost of that good today. An insurer sells a promise today — to pay a claim that may materialise next month, next year, or in thirty years — and does not know the ultimate cost until the promise is fully discharged. Between the premium received and the claim paid sits a long, uncertain gap, and the entire apparatus of insurance accounting exists to estimate, provision for, and periodically revise the size of that gap.

This is why an insurer's balance sheet is dominated by two things a normal company's is not: technical reserves (liabilities representing future claims and unexpired risk) on one side, and a large investment portfolio on the other. For a Nepali life insurer such as Nepal Life Insurance Company (NLIC) or a non-life insurer such as Shikhar Insurance or Prabhu Insurance, the investment portfolio — government securities, fixed deposits with commercial banks, corporate debentures, and listed equities — routinely exceeds the paid-up capital and free reserves several times over. That portfolio is not incidental; it is the second business the insurer runs alongside underwriting, and for reasons covered in Lesson 33.6, it is frequently the more important one for shareholders.

Life versus non-life is the first branching point, and the two are regulated, reserved, and reported differently enough that comparing a life insurer's ratios to a non-life insurer's is close to meaningless. Non-life insurance — fire, motor, marine, engineering, micro-insurance — writes short-tail contracts, typically twelve months, where claims are usually known and settled within a year or two of the policy period. Life insurance writes long-tail contracts — an endowment or term policy can run twenty, thirty, or more years — where the insurer is committing to pricing mortality and investment returns decades into the future. This difference in time horizon is why life insurers carry actuarial liabilities that dwarf their non-life counterparts relative to premium income, and why the appointed actuary (Lesson 33.4) is a permanent fixture in a life insurer's governance in a way no non-life insurer needs to the same degree.

Regulatory detail on the regulator itself matters here, because its identity changed recently enough that older reports and older textbooks still use the earlier name. Nepal's insurance regulator was known for decades as Beema Samiti (the Insurance Board). Under the Insurance Act, 2079 (2022), it was reconstituted and formally began operating as the Nepal Insurance Authority (NIA) in August 2022, with expanded powers over licensing, solvency, actuarial practice, and market conduct. Every directive discussed in this chapter — the Financial Statement Directive, the Risk-Based Capital and Solvency Directive, the actuary appointment guideline — is an NIA instrument, even though older filings and some data vendors still label the regulator Beema Samiti.

Lesson 33.2 — NFRS 17 Arrives: Nepal's Insurance Contracts Standard

The single biggest change to insurance accounting on NEPSE in the last decade is NFRS 17 (Insurance Contracts), Nepal's adaptation of the international standard IFRS 17. The Accounting Standards Board (ASB) Nepal set the mandatory effective date at Shrawan 1, 2080 (July 17, 2023) — meaning fiscal year 2080/81 was the first full reporting year in which every NEPSE-listed insurer, life and non-life, was required to apply it.

What NFRS 17 actually changes is worth being precise about, because "new accounting standard" is easy to wave through as jargon. Under the older regime, an insurer largely recognised premium as revenue when written or over the policy term on a simple pro-rata basis, and set aside reserves using regulator-prescribed formulas that had only a loose link to the economics of the underlying contracts. NFRS 17 instead requires insurers to measure insurance contracts using a current, discounted, probability-weighted estimate of future cash flows, plus a risk adjustment for non-financial risk, plus — critically — a Contractual Service Margin (CSM): a liability representing the unearned profit an insurer expects to make on a group of contracts, which is released into the income statement gradually, as the insurer actually delivers the insurance service, rather than booked upfront.

The CSM is the concept every investor needs to internalize before the rest of this chapter makes sense, because it is the mechanism by which NFRS 17 profit and cash profit diverge. A life insurer can write a large, profitable batch of new policies in a quarter and show comparatively modest reported profit, because most of the expected profit on those contracts sits in the CSM, waiting to be recognised over the life of the policies rather than in the quarter the premium was collected. Growth, under NFRS 17, temporarily depresses reported earnings relative to what old-style accounting would have shown — the opposite of the intuition most equity investors carry from other sectors, where growth flatters the income statement.

Nepal's transition has not been smooth, and it is worth naming the friction honestly rather than presenting NFRS 17 as a settled matter. Industry commentary through 2024 and 2025 repeatedly flagged the same obstacles: a severe shortage of actuaries and specialist IT staff capable of building the discounted cash-flow and CSM models the standard requires; impact assessments at most insurers that stayed qualitative rather than running the full quantitative transition numbers; staff training that stopped at introductory awareness rather than operational competence; and the sheer cost of the data infrastructure needed to track contract groups, discount rates, and risk adjustments over multi-decade policy books. As late as mid-2026, the Accounting Standards Board and the Nepal Insurance Authority were still holding joint sessions to iron out implementation questions — three fiscal years after the mandatory effective date. An investor comparing two insurers' NFRS 17 disclosures in the same reporting period should not assume both applied identical judgment calls on discount rates, contract boundaries, or risk-adjustment methodology; the standard is principles-based and Nepal's insurers are still converging on common practice.

The transition produced a genuinely unusual regulatory response that every dividend-focused investor in this sector needs to know about. Because NFRS 17 profit and the profit calculated under the NIA's own Financial Statement Directive, 2023 can diverge — sometimes substantially, depending on how much profit sits locked in the CSM — insurers found themselves able to report one profit figure for financial-statement purposes and use it as the base for a dividend proposal that regulators judged imprudent relative to the insurer's actual distributable cash and capital position. The NIA's response, tightened further with effect from the fourth quarter of fiscal year 2025/26, was to require insurers to prepare two parallel sets of quarterly financial statements — one under NFRS 17, one under the Financial Statement Directive — and to permit dividend distribution only from the lower of the two resulting profit figures. Where NFRS 17 retained earnings exceed the Financial Statement Directive figure, the excess must be transferred into a non-distributable regulatory reserve, releasable only with NIA approval. Discretionary bonus additions to participating life policies were simultaneously re-anchored to the Risk-Based Capital and Solvency Directive, 2025 rather than to whichever profit number looked more generous.

The upside, and it is real, is comparability going forward. Once Nepal's insurers converge on common NFRS 17 practice, the standard's insistence on current, market-consistent assumptions and a uniform CSM mechanism should make it far easier to compare a life insurer's book quality against a peer's than the old prescriptive-reserve regime ever allowed — the explicit goal cited by regulators and standard-setters is exactly this cross-sector standardisation, giving investors cleaner visibility into risk profiles across the thirteen-odd life insurers and fourteen non-life insurers now listed. The chapter's job is to get you reading the transitional numbers correctly rather than waiting for that convergence to finish.

Lesson 33.3 — Premium Recognition: When Does an Insurer Actually Earn Its Revenue

Even with NFRS 17's overhaul of profit measurement, the underlying question of premium recognition timing is still the right place to start reading any insurer's income statement, because it is the most intuitive of the sector's accounting mechanics and it differs meaningfully between life and non-life business.

For non-life insurance, the operative concept is the unearned premium reserve (UPR). A one-year motor policy sold on the first day of Poush is not "earned" revenue on the day the premium is collected — the insurer has taken on twelve months of risk and has, in effect, been paid in advance for a service it has not yet delivered. Under both the pre-NFRS 17 regime and its replacement, the insurer recognises premium income progressively over the policy period (commonly on a time-apportioned basis, though NFRS 17 formally reframes this as the release of the liability for remaining coverage), holding the unrecognized portion as a liability — the UPR — on the balance sheet. A non-life insurer that wrote an unusually large volume of new business in the last month of the fiscal year will show a large cash and premium-receivable inflow but a correspondingly large increase in unearned premium reserve, muting the reported revenue impact. Investors who look only at gross written premium growth and skip the UPR movement will overstate how much of that growth has actually flowed through to earned income.

Life insurance recognition works differently again, because a life policy is not a single risk period but a bundle of long-duration obligations. Premium is recognised as revenue as it becomes due, but it is matched against a build-up in actuarial liabilities (called, under NFRS 17, the liability for remaining coverage, built from discounted future cash flows plus risk adjustment plus CSM) rather than a simple unearned-premium concept. The practical consequence for a Nepali retail investor is that a life insurer's premium income line tells you almost nothing about profitability in isolation — a policy priced too cheaply relative to the mortality and investment assumptions behind it can generate strong premium growth for years while quietly destroying long-run value, and it is the actuarial reserve movement, not the premium line, that would eventually reveal this.

Premium growth is a volume metric. Reserve movement is where the economics live.

A further wrinkle specific to Nepal's market is the presence of micro-insurance as a distinct, smaller-ticket, high-volume line, now with its own listed entities — Nepal Micro Insurance and Crest Micro Life among them, both having listed on NEPSE. Micro-insurance premium recognition follows the same broad principles as conventional non-life or life business, but the policies are shorter in duration and far higher in count, so the operational burden of correctly computing UPR and claims reserves at the individual-policy level is proportionally larger relative to the premium base — a reason to expect these newer, smaller insurers to lag the established players in NFRS 17 operational maturity, not to assume equivalence just because both file the same standard.

Lesson 33.4 — Claims Reserving and IBNR: Where the Appointed Actuary Earns Their Fee

If premium recognition tells you when an insurer books revenue, claims reserving tells you whether the insurer has honestly estimated what that revenue will eventually cost. This is the single most judgment-laden number in the entire set of insurance financial statements, and it is also the number most prone to being quietly wrong in ways that only surface years later.

Three categories of claims sit on a non-life or general-insurance-style liability schedule. Reported and admitted claims are the easiest — the policyholder has filed, the insurer has assessed the loss, and a specific reserve is booked. Reported but not yet settled (RBNS) claims are still being assessed or disputed but are at least known to exist. The hardest category, and the one that most determines whether an insurer's reserving is prudent or optimistic, is IBNR — Incurred But Not Reported. These are losses that have already happened, within the accounting period, but which the insurer has not yet been notified of: an accident that occurred in the last week of the fiscal year but whose claim will only be filed weeks or months later, or in liability lines, a loss that may not surface for years. IBNR cannot be built from a claims register, because by definition no claim yet exists in that register. It must be estimated statistically, typically by projecting historical claims-development patterns (how claims from past accident periods matured over subsequent reporting periods) forward onto the current period's exposure.

This is exactly the terrain where the appointed actuary function matters, and Nepal's regulatory framework around it has been tightened materially in the last two years. The NIA's Guideline Related to Actuary Appointment for Insurers, 2024 (2081) formalised the statutory role of the Appointed Actuary at each insurer — the professional legally responsible for certifying reserve adequacy, mortality and morbidity assumptions (for life business), and solvency calculations. Because Nepal's domestic actuarial talent pool is thin, the NIA moved in 2024 to mandate that every insurer additionally build out a supporting bench of Actuarial Analysts, effective July 16, 2024, explicitly to support the Appointed Actuary's statutory duties — with those analysts' own performance appraisals required to incorporate the Appointed Actuary's feedback, formalising a reporting line that had previously been informal or absent at smaller insurers.

For a retail investor without access to an insurer's internal claims triangles, the practical proxy for reserving conservatism is watching for two things across successive annual reports: whether prior-year claims reserves are subsequently released as "excess" (a sign reserves were set conservatively and true-up in the insurer's favour) or strengthened (a sign reserves were initially too thin), and whether the actuarial valuation report — which Nepali insurers are required to obtain and which increasingly is referenced or summarised in annual disclosures — flags any change in key assumptions such as discount rates, mortality tables, or expense loadings. A change in discount rate assumption alone can move a life insurer's actuarial liability, and therefore reported profit, by a large margin without a single additional policy being sold or claim being paid — which is precisely why NFRS 17's requirement for insurers to disclose the sensitivity of their reserves to key assumptions is one of the more useful investor-facing improvements the standard brings, once insurers report it with real specificity rather than boilerplate language.

Lesson 33.5 — Solvency Margin and Risk-Based Capital: The Regulator's Real Lever

Solvency is the number the Nepal Insurance Authority cares about more than any single line in the income statement, because it is the direct measure of whether an insurer can pay the claims it has promised to pay. The solvency margin (or solvency ratio) is, at its simplest, available capital divided by the capital the regulator requires the insurer to hold against its risk profile — a ratio above 1.0 means the insurer holds more capital than the bare regulatory minimum, and the further above 1.0, the larger the cushion.

Nepal moved from an older, simpler factor-based solvency margin framework to a full Risk-Based Capital and Solvency Directive, issued in 2024 (2081) and then revised again in 2025 (2082) — two directives in consecutive years, itself a signal that the regulator is still actively calibrating the framework rather than treating it as finished. Under the current regime, the regulatory minimum solvency ratio is 1.3 for life insurers and 1.5 for non-life insurers; an insurer that falls below its minimum faces regulatory restrictions, potentially including limits on dividend distribution and new business writing, well before it becomes genuinely unable to pay claims.

The actual reported numbers across NEPSE's insurers, as of the most recent quarters disclosed, show the sector running well above these floors — which is worth understanding as a market feature rather than assuming it will always hold. For the fourteen listed non-life insurers, based on FY2081/82 fourth-quarter disclosures, solvency ratios ranged as follows:

Industry average across these fourteen companies stood at roughly 3.29 — more than double the 1.5 regulatory floor. Life insurers show a similarly wide cushion: across the twelve listed life companies, the sector average solvency ratio has run around 4.44 against a 1.3 minimum. Two things follow from this. First, a solvency ratio comfortably above the minimum is now the sector norm, not a distinguishing feature of any one company — an investor should not treat "solvency ratio exceeds the regulatory minimum" as meaningful praise on its own; the relevant comparison is against sector peers and against that insurer's own trend over time. Second, and more usefully, the spread between the strongest and weakest names in the table above (roughly 4.66 down to 2.62 among non-life insurers) is real dispersion worth investigating — a company sitting persistently near the bottom of its peer group's solvency range, even while still above the regulatory floor, has less room to absorb a bad underwriting year or a market downturn in its investment book than one sitting near the top.

Capital requirements are the other side of this story, and Nepal's insurance sector lived through a genuine consolidation episode driven directly by a regulatory capital increase. The regulator raised minimum paid-up capital requirements substantially, ultimately settling on Rs 5 arba (Rs 500 crore) for life insurers and Rs 2.5 arba (Rs 250 crore) for non-life insurers, with the compliance deadline extended to Ashad 2080 (mid-July 2023) after most insurers found the original timeline unworkable. Insurers unable to raise fresh capital on their own — through rights issues or bonus capitalisation — within that runway faced a straightforward choice: merge with another insurer to combine capital bases, or fall short of the licensing minimum.

The non-life side of the market saw the same dynamic play out — Sanima General Insurance merged with General Insurance Company to form Sanima GIC Insurance, again against the backdrop of the Rs 2.5 arba non-life capital threshold. For a retail investor, the lesson is that regulatory capital directives in Nepal's insurance sector are not background compliance noise; they have directly reshaped which companies exist on NEPSE today, and a shareholder in a smaller, thinly capitalised insurer should treat "regulator may again raise the capital floor" as a live scenario with real merger, dilution, or delisting consequences, not a remote tail risk.

Lesson 33.6 — Investment Income: The Engine Behind the Underwriting Number

The final piece of the puzzle is understanding where an insurer's profit actually comes from, because for most Nepali insurers, it is not primarily the underwriting result. Insurance accounting conventionally splits the income statement into a technical account (premium income, claims incurred, reserve movements, and underwriting expenses — the pure insurance business) and a non-technical or investment account (income earned on the large pool of invested premium float — government securities, bank deposits, corporate debentures, and listed equities, alongside a smaller allocation to real estate and other permitted assets under NIA investment directives).

For a typical non-life insurer, underwriting margins are often thin or occasionally negative in a bad claims year, and it is investment income — interest on fixed deposits and government securities, dividend income from equity holdings, and realised or unrealized gains on the investment portfolio — that carries the bottom line. For life insurers the relationship is structurally even tighter, because the entire economics of a long-duration life policy depend on the insurer earning an investment return at least equal to the rate implicitly assumed when the policy was priced; an actuarial reserve calculation, at its core, discounts future claim obligations at an assumed investment yield, so persistent underperformance of the actual investment portfolio against that assumed yield is a slow, compounding drag on solvency that shows up in reserve strengthening long before it shows up as a headline loss.

This is also why insurance-sector share prices on NEPSE correlate meaningfully with the broader index and with interest-rate cycles, independent of underwriting performance. When NEPSE rallies, insurers holding meaningful listed-equity portfolios show mark-to-market gains flowing through their investment income; when commercial bank fixed-deposit rates fall, insurers rolling over large deposit books face a slow compression in investment yield that eventually pressures both profitability and the actuarial assumptions behind their reserves. An investor analysing an insurer purely on underwriting ratios — loss ratio, expense ratio, combined ratio — without separately tracking the investment portfolio's composition, yield, and sensitivity to interest rates and equity markets is missing the half of the business that usually matters more to the bottom line.